Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MEDICA GROUP PLC Director's Dealing 2018

Mar 28, 2018

4972_dirs_2018-03-28_731ebc95-bb85-42a6-9816-6c4fb6ac88c1.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 2618J

Medica Group PLC

28 March 2018

Medica Group PLC

Director / PDMR Shareholding

Medica Group PLC (the "Company") announces that on 26 March 2018, the PDMRs listed below were granted options over ordinary shares of 0.2p each in the Company under the Company's Performance Share Plan 2017 at a nil exercise price:

Name of PDMR Number of shares subject to option
John Michael Graham 211,864
Anthony Leonard Lee 148,305
Dr Stephen Griffith Davies 211,864
Kevin Patrick Terrins 137,711
Sarah Joanne Burns 105,932

The notifications set out below are provided in accordance with the requirements of the EU Market Abuse Regulation, and set out more details of the transactions.

1. Details of PDMR
(a) Name 1.           John Michael Graham

2.           Anthony Leonard Lee

3.           Dr Stephen Griffith Davies

4.           Kevin Patrick Terrins

5.           Sarah Joanne Burns
2. Reason for notification
(b) Position / status 1.           Chief Executive Officer

2.           Chief Financial Officer

3.           Medical Director and Responsible Officer

4.           Business Development Director

5.           Chief Operating Officer
(c) Initial notification / amendment Initial notification in each case
3. Details of the Issuer
(a) Name Medica Group PLC
(b) LEI
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) have been conducted
(a) Description of the financial instrument Ordinary shares of 0.2p each in the capital of the Company ("Shares")
(b) Nature of the transaction Grant of options to acquire Shares pursuant to the Company's Performance Share Plan 2017
(c) Price(s) and volume Option Price nil in each case

1.           211,864

2.           148,305

3.           211,864

4.           137,711

5.           105,932
(d) Aggregated information N/A
(e) Date of the transaction 26 March 2018
(f) Place of the transaction Outside a trading venue

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHFKFDDDBKDANB